S28 Molecular Level Exploration of GPCR Structure, Function, and Regulation

Program: Symposia
Basic/Translational Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 253 (BCEC)
P. Michael Conn, PhD, Texas Tech University Health Sciences Center, Lubbock, TX

Nothing to Disclose: PMC
8:15 AM
Andrew Kruse, PhD, Biological Chemistry and Molecular Pharmacology, Harvard University, Boston, MA
Nothing to Disclose: AK
8:45 AM
Stephane A Laporte, PhD, Room E02.7238, McGill University/McGill Univerity Health Center, Montreal, QC, Canada
SAL: Coinvestigator, Domain Therapeutics.
9:15 AM
Brian Finan, PhD, Institute for Diabetes and Obesity, Helmholtz Zentrum München and Department of Medicine, Technische Universität München, Munich, Germany, Germany
Nothing to Disclose: BF
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire